Targeting cisplatin resistance in breast cancer using a combination of Thymoquinone and Silymarin: an in vitro and in vivo study


	The anti-proliferative assay (MTT) was used to examine the EMT-6/P and EMT-6/CPR cell lines’ sensitivity to cisplatin at varying doses.

Part of: Hamed RA, Talib WH (2024) Targeting cisplatin resistance in breast cancer using a combination of Thymoquinone and Silymarin: an in vitro and in vivo study. Pharmacia 71: 1-19. https://doi.org/10.3897/pharmacia.71.e117997